BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32520761)

  • 21. A unique uterine cervical "teratocarcinosarcoma": a case report.
    Ito K; Yano M; Ogasawara A; Miwa M; Kozawa E; Yasuda M
    Diagn Pathol; 2019 Nov; 14(1):122. PubMed ID: 31684979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.
    Kunimasa K; Nakamura H; Sakai K; Tamiya M; Kimura M; Inoue T; Nishino K; Kuhara H; Nakatsuka SI; Nishio K; Imamura F; Kumagai T
    Lung Cancer; 2019 Jun; 132():59-64. PubMed ID: 31097095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]   [Full Text] [Related]  

  • 27. SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma.
    Gandhi JS; Alnoor F; Sadiq Q; Solares J; Gradowski JF
    Pathol Res Pract; 2021 Mar; 219():153341. PubMed ID: 33581550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
    Chatzopoulos K; Boland JM
    Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
    Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
    Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.
    Kupryjańczyk J; Dansonka-Mieszkowska A; Moes-Sosnowska J; Plisiecka-Hałasa J; Szafron L; Podgórska A; Rzepecka IK; Konopka B; Budziłowska A; Rembiszewska A; Grajkowska W; Spiewankiewicz B
    Pol J Pathol; 2013 Dec; 64(4):238-46. PubMed ID: 24375037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIK3CA somatic mutation in sinonasal teratocarcinosarcoma.
    Belardinilli F; De Vincentiis L; D'Ecclesia A; Giannini G; Giangaspero F; Corsi A
    Auris Nasus Larynx; 2021 Jun; 48(3):530-534. PubMed ID: 32389511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
    J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation-based classification of sinonasal tumors.
    Jurmeister P; Glöß S; Roller R; Leitheiser M; Schmid S; Mochmann LH; Payá Capilla E; Fritz R; Dittmayer C; Friedrich C; Thieme A; Keyl P; Jarosch A; Schallenberg S; Bläker H; Hoffmann I; Vollbrecht C; Lehmann A; Hummel M; Heim D; Haji M; Harter P; Englert B; Frank S; Hench J; Paulus W; Hasselblatt M; Hartmann W; Dohmen H; Keber U; Jank P; Denkert C; Stadelmann C; Bremmer F; Richter A; Wefers A; Ribbat-Idel J; Perner S; Idel C; Chiariotti L; Della Monica R; Marinelli A; Schüller U; Bockmayr M; Liu J; Lund VJ; Forster M; Lechner M; Lorenzo-Guerra SL; Hermsen M; Johann PD; Agaimy A; Seegerer P; Koch A; Heppner F; Pfister SM; Jones DTW; Sill M; von Deimling A; Snuderl M; Müller KR; Forgó E; Howitt BE; Mertins P; Klauschen F; Capper D
    Nat Commun; 2022 Nov; 13(1):7148. PubMed ID: 36443295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.
    Kolin DL; Quick CM; Dong F; Fletcher CDM; Stewart CJR; Soma A; Hornick JL; Nucci MR; Howitt BE
    Am J Surg Pathol; 2020 Feb; 44(2):263-270. PubMed ID: 31567195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinonasal teratocarcinosarcoma in an adolescent male.
    Agrawal N; Chintagumpala M; Hicks J; Eldin K; Paulino AC
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):e304-7. PubMed ID: 22935665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.